The community site for and by
developmental and stem cell biologists

POSTDOCTORAL POSITIONS in USA

Posted by , on 14 June 2011

Closing Date: 15 March 2021

POSTDOCTORAL POSITIONS are available to study the cellular and molecular mechanisms controlling the development of the lymphatic vasculature and its functional roles in normal and pathological conditions including obesity and cancer using available mouse models. Highly motivated individuals who recently obtained a PhD or MD degree and have a strong background in molecular, cancer and developmental biology are encouraged to apply. Interested individuals should send their curriculum vitae, a brief description of their research interests, and the names of three references to:

  • Guillermo Oliver, PhD, Member
  • Department of Genetics
  • St. Jude Children’s Research Hospital
  • 332 N. Lauderdale, Memphis, TN 38105
  • E-mail: guillermo.oliver@stjude.org
  • http://www.stjude.org/oliver
Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs

Navigate the archive

Use our Advanced Search tool to search and filter posts by date, category, tags and authors.

Visualizing stem cells at home

Posted by , on 13 June 2011

The Drosophila ovary is stunningly beautiful, and a playground of wonderful biological questions.  Within the germarium alone, developmental biologists can look at asymmetric division, stem cells and their niches, cell migration, and cell specification.  A recent paper in Development describes a technique allowing the in vitro imaging of a fruit fly ovary, and opens the door for further studies of development and stem cells.

The Drosophila ovary is composed of about 15 ovarioles, which each houses an organ called the germarium that serves as the assembly line for egg production.  In the germarium, two types of stem cells play important roles – germline stem cells and follicle stem cells.  Germline stem cells divide to kick off the egg production process, while follicle stem cells divide to provide several different types of ovarian follicle cells.  A recent paper by Morris and Spradling describes a technique allowing the live imaging of a developing follicle.  After dissecting and imaging an ovariole in culture, Morris and Spradling were able to monitor cell division, orientation, and movement during follicle generation for a prolonged period.  This technique allows biologists to address many unanswered questions about follicle generation and stem cell biology, as both populations of stem cells can be imaged simultaneously and in their own niches.

Images show a cartoon and high-resolution images of a fruit fly germarium, with germline stem cells (GSC) marked in pink and follicle cells in green (FSC are follicle stem cells).  BONUS!!  For a cool movie of a germarium showing cell divisions and dynamic movement, click here.

For a more general description of this image, see my imaging blog within EuroStemCell, the European stem cell portal.

ResearchBlogging.org

Morris, L., & Spradling, A. (2011). Long-term live imaging provides new insight into stem cell regulation and germline-soma coordination in the Drosophila ovary Development, 138 (11), 2207-2215 DOI: 10.1242/dev.065508

Thumbs up (1 votes)
Loading...

Tags: , , ,
Categories: Images, Research

Put your party hats on

Posted by , on 13 June 2011

If you take a look at our Facebook and Twitter pages today, you might notice that they look slightly different. Our regular logo is temporarily replaced with a special logo to celebrate our upcoming first birthday. That’s right – it’s been one year already!

Our official birthday is on June 22nd, and if you check the Node that day, we’ll have a small virtual present for all our readers, as well as a quick look back over the past year.

Thumbs up (5 votes)
Loading...

Tags:
Categories: News

Embryonic development informs adult heart repair

Posted by , on 9 June 2011

After a heart attack, heart muscle is irreparably damaged, but a paper in Nature now reports that adult mouse hearts have a source of progenitor cells that can form new muscle cells after heart injury.

A few years ago, studies showed that embryonic epicardial progenitor cells contribute to the cardiomyocyte lineage in developing mouse hearts. These cells were marked by the expression of a key embryonic epicardial gene, Wt1, but Wt1 is not expressed in adult tissues.

The group of Paul Riley at UCL now reactivated Wt1 expression in adult mouse hearts by priming them with thymosin β4 (Tβ4) and inducing injury. This pointed to an adult pool of progenitor cells, marked by Wt1, which could form new cardiomyocytes after myocardial infarction. What’s more, this process was upregulated in response to Tβ4. A few years ago, Riley’s group already showed that Tβ4 also induces formation of blood vessels from epicardial progenitors.

In a video interview with The Scientist, Riley summarized his paper, and emphasized how they built upon previous studies in embryonic heart development to find this new source of adult myocardial progenitors.

Repairing hearts from thescientistllc on Vimeo.

“The key point for us has always been moving back to embryonic development and identifying cells that are key to formation of the organ, that would then translate to repair in the adult.” – Paul Riley (from the interview above)

How exactly Tβ4 induces increased Wt1 expression and cardiomyocyte formation isn’t yet known, but could this be a new therapeutic for heart attack patients? Unfortunately, Tβ4 is not the most practical drug. It would need to be administered before a heart attack, so could only be used as a preventive measure for people who already know they’re at risk, and it’s not available as a pill – only as injection. But a big step toward any form of therapy would be to find out how Tβ4 works at a molecular level to differentiate the progenitor cells to cardiomyocytes upon injury, and, as Riley mentions in the video above, that will be the next step in their research.

update: F1000/The Scientist have some more videos from this lab on their blog.

(more…)

Thumbs up (1 votes)
Loading...

Tags: , ,
Categories: Research, Video

Round-up of alternative careers stories

Posted by , on 8 June 2011

In December we asked people to share how they moved from research to a career away from the lab bench. Since then, we’ve heard from a number of people, and a few stories are still coming in. Here’s the list so far, with current affiliations:

Keep up and blog on – my route to the Node
Eva Amsen – Community manager for the Node and Online Editor for Development

A career in publishing – a developing story
Jane Alfred – Executive Editor for Development

Educational game designer: where biology, games, and technology meet
Nicole Husain – educational game designer at Spongelab Interactive

From the bench to the science centre
Sarah Gibb – Science and Interpretation Officer at Glasgow Science Centre

A career as editor
Vivian Siegel – Director of the Center for Science Communication at Vanderbilt University, and Editor-in-Chief of Disease Models and Mechanisms.

My transition to patent law
Michael Belliveau – Patent Attorney at Clark & Elbing

My journey to scientific editing
Kara Cerveny – scientific editor at Cell

My journey from bench scientist to clinical ethicist
Michael Szego – fellow in clinical and organizational ethics at the University of Toronto Joint Centre for Bioethics

How fate determined my career as a science journalist
Claire Ainsworth – science journalist

Keeping an open mind – a scientist’s quest for positive change
Sobia Hamid – entrepreneur

Thumbs up (2 votes)
Loading...

Tags:
Categories: Careers

In Development this week (Vol. 138, Issue 13)

Posted by , on 7 June 2011

Here are the highlights from the current issue of Development:

Mutant Xist merely muffles X chromosome

In XX female mammals, inactivation of one X chromosome during development equalises the levels of X-linked gene products in females with those in males. Expression of the Xist gene from one of the two X chromosomes produces a non-coding RNA that coats and silences the chromosome from which it is transcribed. But how does Xist RNA induce chromosome silencing? XistIVS, an Xist mutant generated in mice by gene targeting, may help to answer this question, suggest Takashi Sado and co-workers (see p. 2649). In embryos carrying the XistIVS allele, they report, XistIVS is differentially upregulated, and its mutated transcript coats the X chromosome in cis in embryonic and extra-embryonic tissues, but X-inactivation is incomplete. This partial X-inactivation seems to be unstable, and the mutated X chromosome is reactivated in some extra-embryonic tissues and possibly in early epiblastic cells, suggesting that the RNA encoded by XistIVS is dysfunctional. Further studies of this unique mutation could thus reveal exactly how Xist RNA induces chromosome silencing.

It’s a wrap: Gpr126 and myelination

In the vertebrate peripheral nervous system, Schwann cells form the myelin sheath, the multilayered membrane that insulates axons and allows the rapid propagation of electrical signals. Now, on p. 2673, William Talbot and colleagues report that, as in zebrafish, the orphan G-protein-coupled receptor Gpr126 is essential for myelination and other aspects of peripheral nerve development in mammals. The researchers show that a mutation in Gpr126 causes a severe congenital hypomyelinating peripheral neuropathy in mice and reduces the expression of differentiated Schwann cell markers. In addition, Gpr126 mutant mice lack Remak bundles (the non-myelinating Schwann cells associated with small calibre axons), and exhibit delayed sorting of large calibre axons by Schwann cells, suggesting that the Schwann cells are arrested at the promyelinating stage. Finally, they report, Gpr126 mutant mice develop abnormalities in the perineurium (the connective tissue that surrounds each nerve fibre bundle). Given these results, the researchers suggest that Gpr126 might represent a target for the treatment of demyelinating diseases of nerves.

Production rates scale the Bicoid gradient

Embryonic patterning is insensitive to embryo size. Consequently, despite size variations among individuals in a population, their body parts are proportionate or ‘scaled’. But how is scaling achieved and do similar mechanisms control within-species and between-species scaling? On p. 2741, Jun Ma and colleagues use embryos from Drosophila melanogaster lines selected for large and small egg volumes to investigate the within-species scaling of the Bicoid (Bcd) morphogen gradient. They show that large embryos contain more maternal bcd mRNA than small embryos and, as a result, have higher anterior nuclear Bcd concentrations. This difference in the anterior production rate of Bcd leads to the scaling properties of the Bcd gradient. That is, in broad regions of large and small embryos, similar Bcd concentrations are found at the same relative embryonic positions. Thus, propose the researchers, unlike between-species scaling, which probably involves species-specific differences in Bcd diffusion and/or decay rates, within-species Bcd gradient scaling depends on the scaling of Bcd production rates with embryo volume.

Plane speaking: the roles of Dachsous and Frizzled

In epithelial tissues, the polarisation of cells within the plane of the tissue helps to coordinate morphogenesis. The Dachsous (Ds) and Frizzled (Fz) signalling systems play key roles in establishing and maintaining this planar polarity but how these systems interact is unclear. Now, on p. 2751, Seth Donoughe and Stephen DiNardo report that the ds and fz genes contribute separately to planar polarity in the Drosophila ventral epidermis. The cuticle of fly larvae is covered with denticles, protrusions that help the larvae move. To investigate how this polarised pattern of denticles is established, the researchers developed a semi-automated method that measures the orientation of individual denticles in the ventral epidermis. Their analyses of various mutants show that ds and fz contribute independently to polarity, that they act over spatially distinct domains, and that the Ds but not the Fz system polarises tissue equally well across small and large field sizes. These and other results provide new insights into the planar polarity machinery.

LMO4: a co-activator of neurogenin 2 in the CNS

Numerous transcription factors regulate the generation and migration of neurons during the development of the central nervous system but the co-factors that support their activity remain unclear. Here (p. 2823), Soo-Kyung Lee and co-workers identify the LIM-only protein LMO4 as a co-activator of the proneural transcription factor neurogenin 2 (NGN2) in the developing mouse cortex. The researchers show that LMO4 and its binding partner nuclear LIM interactor (NLI) form a multi-protein transcription complex with NGN2. This complex, they report, is recruited to the E-box-containing enhancers of NGN2 target genes, which regulate various aspects of cortical development, and activates NGN2-mediated transcription. Consistent with this finding, the researchers demonstrate that neuronal differentiation is impaired in the cortex of Lmo4-null embryos, whereas expression of LMO4 facilitates NGN2-mediated migration and differentiation of neurons in the embryonic cortex. These results suggest that the LMO4:NLI module promotes the acquisition of cortical neuronal identities by forming a complex with NGN2 and subsequently activating NGN2-dependent gene expression.

First blood: in vitro haematopoiesis

The conversion of embryonic stem (ES) cells into haematopoietic precursors in vitro could have important clinical applications, but strategies that achieve this feat usually require the use of feeder cells or serum. Now, Po-Min Chiang and Philip Wong describe a method for converting murine ES cells into endothelial cells and blood precursors at low cell densities in a serum-free defined medium (see p. 2833). The researchers identify a set of cytokines and small molecules that are necessary and sufficient to convert ES cells into definitive haematopoietic precursors within 6 days, and by tracking the fate of single progenitors with time-lapse video microscopy they follow this stepwise differentiation process. The determination of haemogenic fate, they report, occurs as early as day 4 of this differentiation protocol. Moreover, BMP4 plays essential time-sensitive roles in both angiogenesis and haemogenesis. This protocol, the researchers suggest, could thus serve as a framework for future studies of human haematopoiesis and for the development of treatments for haematopoietic disorders.

Plus…

As part of the Evolutionary crossroads in developmental biology series, David McClay introduces the sea urchins and discuss how studies of sea urchins have contributed significantly to our understanding of the developmental mechanisms used to build a deuterstome organism.
See the Primer article on  p. 2639

The recent Keystone Symposium on Evolutionary Developmental Biology presented an opportunity to showcase the latest research findings in this multidisciplinary field and, as reviewed by Haag and Lenski, revealed a growing relevance of this research to both basic and biomedical biology.
See the Meeting Review on p. 2633

Thumbs up (1 votes)
Loading...

Tags: , , , , , , , , , , , , , ,
Categories: Research

Select a Development cover – round 3

Posted by , on 6 June 2011

The annual Embryology course at Woods Hole starts again this week. Best of luck to all participants! We thought it was an appropriate time to launch the third voting round to choose a Development cover from images taken by the students in last year’s course.

Meanwhile, the winning image from the first round – a sea urchin chomping down on a piece of seaweed – will appear on the cover of Development vol. 138 issue 13, which will go live online on June 7 (tomorrow!). The image on the left is a sneak preview of the cover. That issue also contains a primer article about sea urchins as model organism, so the cover was a good fit!

Which of these images will be next to appear on the cover of Development? Please vote in the poll below the images. (Click any image to see a larger version.) You can vote until June 20, 12:00 (noon) GMT

1. Dorsal view of the central nervous system of a Drosophila embryo. Neurons and axons are stained with anti-HRP (red). A distinct subset of neurons express even-skipped (green). Nuclei of the body wall stained with DAPI (blue). This image was taken by Joshua Clanton (Vanderbilt University).

2. Pilidium larvae of the Nermertean, Cerebratulus lacteus. Acetylated tubulin (green), serotonin (red), nuclei (blue, DAPI). This image was taken by Meii Chung (UT Austin).

3. Planaria stained with MF20 (green), phalloidin (red) and DAPI (blue). This image was taken by Valeria Merico (University of Pavia).

4. Drosophila embryo (stage 16) immunostained to detect Tropomyosin (purple) in the developing muscle, the Hox gene Ultrabithorax (green), and Spalt (red). This image was taken by Elise Delagnes and Hannah Rollins (UC Berkeley).


Thumbs up (1 votes)
Loading...

Tags: ,
Categories: Images

My journey from bench scientist to clinical ethicist

Posted by , on 1 June 2011

Four and a half years ago I was introduced to the field of clinical ethics while nearing the end of my Doctorate in Molecular Genetics at the University of Toronto. After attending a talk given by Kerry Bowman, a clinical ethicist at one of the University teaching hospitals, I approached him with some additional questions. The ensuing discussion led to a productive working relationship. Initially, I helped him perform an ethics analysis of a complicated genomics project. He then invited me to participate in some of his other professional responsibilities, opening a door into a new profession. This foray into clinical ethics had a lasting effect; in short order I decided to retire my pipette and pursue a career in clinical ethics.

At the beginning of my PhD, my intention was to pursue a career as an academic scientist. Like many graduate students I experienced both euphoric moments when critical experiments worked and frustrating periods when experiments were not informative. While I enjoyed the scientific process, I had a nagging feeling that a scientific career was not the perfect fit for me. Accordingly, I tried to keep an open mind and got involved in extracurricular activities. I participated in student governance, got involved in science outreach and taught with a non- governmental organization overseas. I also regularly attended a life science career development seminar series meant to expose graduate students to careers outside of academic science. I first met Kerry when he talked about clinical ethics at one of these seminars.

What immediately captured my imagination was the interesting breadth of activities performed by clinical ethicists. In Canada, most large hospitals either employ their own clinical ethicist(s) or have access to a regional clinical ethics service. Clinical consultations are the bread and butter of most clinical ethics programs and are usually triggered by an ethical tension in the provision of patient-care. A conflict regarding a treatment decision or plan, complicated end-of-life decision making, whether to withdraw life support, consent and capacity issues, and disagreement about discharge planning are all examples of clinical cases that may benefit from clinical ethics support. On the organizational level, many ethicists are also involved in the development of hospital policy since good policies may help mitigate future ethical tensions. Teaching is another important facet of clinical ethics. Education serves to raise awareness about ethical issues and can increase the capacity of healthcare workers and researchers to deal with ethical issues in their practice. Many ethicists also conduct independent research and serve on hospital research ethics boards (the Canadian equivalent of research ethics committees).

After deciding on a career track, I knew I needed more education. To address my knowledge gap, I enrolled in a Bioethics Masters program at the University of Toronto. I was fortunate enough to get a scholarship and worked hard over the two year degree to immerse myself into the field of bioethics. I took a generalist approach and chose a course-based professional masters program, which allowed me to take more courses compared to the thesis-based program that was also offered. I completed the degree and am currently a fellow in clinical and organizational ethics at the University of Toronto Joint Centre for Bioethics. The fellowship program is analogous to an apprenticeship program in ethics. Each fellow rotates through the ethics programs of four partner healthcare institutions over the course of a year (3 months is spent at each site). This unique and wonderful experience has given me practical ethics experience that complements the theoretical knowledge I learned in graduate school.

How has a PhD in molecular genetics prepared me for a career in ethics? Interestingly, several of my patients and non-ethicist colleagues have asked about my background and only about half immediately appreciate why a background in genetics might be useful in ethics. The other half usually can’t get over the fact that most of my training is not in philosophy. I view my background in science to be of great relevance. I am able to understand the science behind many emerging technologies in medicine, which is critically important in order to discuss the ethical implications of new technology and recommendations on how to proceed. My science training also heavily contributed to the development of my analytic, writing and presentation skills, which nicely compliments my bioethics education.

The combination of science and clinical ethics training is still quite unusual and has afforded me some unique opportunities. For example, I have been embedded in a genomics centre at a large research institute to work on ethical issues in parallel with scientific innovation. I have also been invited to speak at several interesting venues on topics involving genetics and ethics. As my fellowship is drawing to an end, I am seeking out clinical ethics positions that will allow me to perform all the clinical activities I described earlier and also use my genetics knowledge in a research ethics capacity. I hope to continue working closely with scientists and work on the ethics of the new research as it is being developed. Although not yet employed as a clinical ethicist, I was recently asked to give a talk about clinical ethics at the same seminar series that first introduced me to the field. I graciously accepted and am looking forward to describing my exciting field to other life science students.

Thumbs up (5 votes)
Loading...

Tags: ,
Categories: Careers

Postdoc position – Melbourne Australia

Posted by , on 1 June 2011

Closing Date: 15 March 2021

Position Available: POST DOCTORAL RESEARCHER

With A/Prof Helena Richardson

Cell Cycle and Development Lab

Peter MacCallum Cancer Centre

Melbourne, Victoria Australia

Project: Apico-basal polarity regulators, Signalling pathways and Tumourigenesis

Available from Sept 2011 – contract initially 1 year with scope for extension

 

Our lab uses Drosophila as a model of tumour development, and through collaboration to translate this into mammalian systems. We seek a highly motivated, suitably experienced and qualified individual with a PhD (or submitted PhD thesis). Knowledge and experience in Drosophila Cell Biology, Genetics, Molecular Biology and Biochemistry is essential, and expertise in Drosophila imaginal disc biology and tissue culture is desirable. Applicants must have good organisational and communication skills, attention for detail, and the ability to carry out work efficiently and independently.

The Peter MacCallum Cancer Centre is Australia’s foremost Cancer Centre, and has an internationally renowned research division covering Cancer Cell Biology, Genomics and Immunology.

 

Peter Mac offers its employees the following benefits:

  • Salary Packaging
  • Employee Assistance Program
  • Central City Location
  • Supported Education Programs
  • Training and Development Program

 

Please send your CV to email: Helena.Richardson@petermac.org

For further information on my lab see:  http://www.petermac.org/Research/CellCycleDevelopment

Thumbs up (No Ratings Yet)
Loading...

Tags: , ,
Categories: Jobs

Post-doctoral position (2 years) Use of stem cells to generate tendons

Posted by , on 1 June 2011

Closing Date: 15 March 2021

A 2 year post-doc position is available from October 2011 in Delphine DUPREZ’s team, in Paris.

Tendon and ligament injuries are common clinical problems during aging or following accidents. No treatment currently exists to restore injured or defective tendon/ligament to its normal condition. The ultimate aim of this project is to build an in vitro tendon (or ligament) for implantation into patients with defective tendons. The global strategy is to use the knowledge that we have acquired (and that we are currently acquiring) concerning tendon formation during embryonic development using the chick and mouse models (Lejard et al., 2011 J. Biol. Chem 286(7), 5855-5867, Wang et al., 2010 Dev Cell, 18, 643-654, for review Tozer and Duprez, 2005, Birth Defects Res C Embryo Today. 75(3), 226-36) in order to establish an artificial tendon.

The project will involve cell culture of adult mesenchymal stem cells and transfection experiments with the appropriate factors in order to trigger cell differentiation towards a tendon phenotype. The project will also require in vivo manipulations in chick embryos, the use of mouse mutant lines and the use of rat tendon injury models.

A background in mesenchymal stem cells and/or cell culture will be an advantage.

Applicants may be of any nationality and should have obtained the equivalent of a PhD. Salary will be at least 2500 Euros per month (depending upon experience). Applications including a CV, a description of previous research experience, and 2 or 3 names of referees should be sent to Delphine DUPREZ to Delphine.duprez@upmc.fr

Thumbs up (No Ratings Yet)
Loading...

Categories: Jobs